FDA greenlights GSK vaccine for infants against bacteria linked to meningitis. The FDA had twice declined to approve the vaccine, and required the drugmaker to produce additional data. MenHibrix will be used against Neisseria meningitidis or meningococcal disease and Haemophilus influenzae, or Hib, type b bacterial diseases, which can cause life threatening complications like sepsis if they infect the bloodstream and meningitis if they infect the lining of the brain, according to a statement from the regulator.
Supreme Court may ax Obamacare, but obamacare will live on. Whatever happens, one thing is clear. Even if all nine justices throw out Obamacare as it was envisioned, obamacare – the principles that form the backbone of healthcare reform and the Patient Protection and Affordable Care Act – will live on. Stakeholders from across the healthcare spectrum seem united on that.
More open innovation, collaboration needed to fill pharma’s pipelines. Open innovation and cooperation in the pharmaceutical industry will continue to gain traction as patent losses and R&D cutbacks force drug companies to look outside of their own walls for promising technologies, according to a new report from GBI Research.
4 unexpected mobile health findings from physicians, payers and patients.A report by PricewaterhouseCoopers exploring the opportunities for using mobile health and the potential barriers for its growth challenges some assumptions made about how physicians, payers and patients are thinking about this area, such as how it is perceived by young physicians and how physicians would like it to be used.
Stealth-mode surgical device maker raises $6.5 million. According to a 2011 patent application, JustRight Surgical’s device is smaller in size than previous devices and uses radio-frequency energy to seal blood vessels in “micro-surgical procedures, difficult to access anatomy or pediatric general surgery.”